| Literature DB >> 33004735 |
Dong Xu1, Minghua Ge2, Ankui Yang3, Ruochuan Cheng4, Hui Sun5, Hongcheng Wang6, Jianquan Zhang7, Zhigang Cheng8, Zeyu Wu9, Zhongmin Wang10, Bo Zhai11, Yin Che12, Lin Chen13, Liyu Chen1, Wen Cheng14, Gang Dong15, Peiyan Duan16, Weijun Fan17, Jian Fei18, Rongzhan Fu19, Meizhuo Gao20, Pintong Huang21, Tianan Jiang22, Jian Kuang23, Honghao Li24, Ping Li25, Xinying Li26, Zhihui Li27, Man Lu28, Yukun Luo8, Huadong Qin28, Jianwu Qin29, Zhuo Tan2, Lina Tang30, Zhaohui Wang31, Shurong Wang32, Xiaoping Wang33, Gaosong Wu34, Xiaoyan Xie35, Haimiao Xu36, Detao Yin37, Xinguang Qiu37, Y Jichun38, Jianjun Yu39, Weiwei Zhan40, Fujun Zhang17, Junqing Zhang41, Rongqin Zheng42, Xiangqian Zheng43, Yuanyi Zheng44, Youhua Zhu45, Yinghua Zou46, Zhiqiang Meng47, Xin Ye48, Hailiang Li49, Xiao Li50, Zhengyu Lin51, Lijing Wang1, Liping Wang1, Chen Yang1, Yifan Wang1, Linyan Zhou1, Di Ou1, Jiafeng Wang2, Ming Gao43, Huixiong Xu52, Ping Liang8, Gaojun Teng53.
Abstract
As a treatment option for cancer, thermal ablation has satisfactory effects on many types of solid tumors (such as liver and renal cancers). However, its clinical applications for the treatment of thyroid nodules and metastatic cervical lymph nodes are still under debate both in China and abroad. In 2015, the "Zhejiang Expert consensus on thermal ablation for thyroid benign nodules, microcarcinoma, and metastatic cervical lymph nodes (2015 edition)," was released by the Thyroid Cancer Committee of Zhejiang Anti-Cancer Association, China. To further standardize the application of thermal ablation for thyroid tumors, the Thyroid Tumor Ablation Experts Group of Chinese Medical Doctor Association has organized many seminars and finally produced a consensus to formulate the "Expert consensus workshop report: Guidelines for thermal ablation of thyroid tumors (2019 edition)."Entities:
Keywords: Ablation techniques; consensus; guideline; nodular goiter; thyroid neoplasms
Mesh：
Year: 2020 PMID： 33004735 DOI： 10.4103/jcrt.JCRT_558_19
Source DB: PubMed Journal: J Cancer Res Ther ISSN： 1998-4138 Impact factor: 1.805